Senseonics Holdings, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Senseonics Holdings, Inc. reports increased revenue and gross profit for 2025, driven by the Eversense 365 launch and regaining commercialization rights from Ascensia, despite ongoing net losses and liquidity concerns.
NASDAQ
Senseonics Holdings, Inc. files its 10-K report for the year ended December 31, 2024, detailing its financial performance and strategic advancements in the global commercialization of its Eversense CGM systems.
NASDAQ
Senseonics Holdings, Inc. released its 2023 annual report, detailing financial performance and strategic advancements in its glucose monitoring technology.